Liberating Molecular Biology From the 1-G Gravitational Constraint.
For 3.8 billion years, every cellular process on Earth evolved immersed in a constant 9.8 m/s² gravitational vector. Density differentials induce buoyant convection, shearing fragile molecular assemblies and triggering rapid mechanical decoherence.
BioGravity was founded in 2024 to operate continuous quantum biophysics experiments in Low Earth Orbit (LEO). In weightlessness, buoyancy collapses to zero. Diffusion becomes the sole mode of transport, enabling sub-angstrom crystal growth, extended quantum spin superposition in enzymatic active sites, and true 3D scaffold-free cellular self-organization.
Low Earth Orbit Experimental Bays
Select an orbital laboratory module to inspect active hardware, sensors, and ongoing runs.
Principal Investigators & Biophysicists
The interdisciplinary team uniting quantum physics, space medicine, and structural enzymology.
Former CERN quantum optics fellow and lead investigator on hydrogen tunneling in CRISPR-Cas9 catalytic cleavage triads. Over 180 flight-experiment cycles.
Pioneered diffusion-limited nucleation of transmembrane ABC transporters. Achieved world-record 0.82 Å resolution on CFTR channels in microgravity.
Architect of orbital acoustic levitation bioprinting systems. Developed vascularized cardiac spheroids demonstrating 90-day rhythmic synchrony.
Orbital Lab Notes & Breakthrough Timeline
Cas9 Quantum Tunneling Verified at 4.2 K
Isotope exchange kinetics under zero-G confirm non-classical wave-packet mechanics during ribonucleoprotein target cleavage.
First Scaffold-Free Vascularized Micro-Organoid Bioprinted
Acoustic levitation wells successfully assemble human cardiac endothelial cells into functional capillaries without hydrogel scaffolds.
0.82 Å Atomic Crystallography Milestone
Membrane protein crystal grown aboard Module Beta yields sub-angstrom resolution with zero buoyancy convection defects.
BioGravity Orbital Platform Deployed to 51.6° LEO Orbit
Station core successfully achieves autonomous stabilization with residual gravity envelope below 0.1 μg.
Understanding Quantum Biotechnology
Inquire for Orbital Payload Integration
Submit your laboratory's compound or biological protocol for next-cycle orbital testing.